Oportunidades de investigación en preeclampsia, desde la perspectiva de prevención primaria. Un artículo de reflexión

Autores/as

  • Luis Alfonso Díaz-Martínez
  • Norma Cecilia Serrano-Díaz

DOI:

https://doi.org/10.18597/rcog.405

Resumen

Introducción: en este ensayo se presentan algunos campos de investigación en los que, desde una perspectiva de prevención de la preeclampsia, es necesario trabajar para adelantar estudios e intervenciones de calidad, necesarios para esclarecer dudas o vacíos, todo con miras a reducir el impacto que la entidad tiene en nuestra población.

Hechos: algunos de los campos en donde hay in-consistencias en la información disponible son los de la incidencia de la preeclampsia, sus factores de riesgo, las consecuencias a corto y largo plazo de sufrirla, la percepción que tienen las embarazadas sobre la preeclampsia, o la utilidad de muchas de las medidas de prevención poblacionales propuestas.

Conclusiones: se propone que estas deficiencias se pueden resolver de una manera más eficiente al vincular los conocimientos que se tienen de la fisiopatología de la entidad con las estrategias de intervención e investigación en epidemiología y salud pública.

Biografía del autor/a

Luis Alfonso Díaz-Martínez

Centro de Investigaciones Biomédicas, Facultad de Ciencias de la Salud, Universidad Autónoma de Bucaramanga, Bucaramanga, Colombia. Correspondencia: Dr Díaz, Calle 157 # 19-55, Centro de Investigaciones Biomédicas, Facultad de Ciencias de la Salud, Universidad Autónoma de Bucaramanga, Bucaramanga, Colombia.

Norma Cecilia Serrano-Díaz

Centro de Investigaciones Biomédicas, Facultad de Ciencias de la Salud, Universidad Autónoma de Bucaramanga, Bucaramanga, Colombia. Correspondencia: Dr Díaz, Calle 157 # 19-55, Centro de Investigaciones Biomédicas, Facultad de Ciencias de la Salud, Universidad Autónoma de Bucaramanga, Bucaramanga, Colombia.

Referencias bibliográficas

Moodley J. Maternal deaths due to hypertensive disorders in pregnancy. Best Pract Res Clin Obstet Gynaecol 2008;22:559-67.

Moster D, Lie RT, Markestad T. Long-term medical and social consequences of preterm birth. N Engl J Med 2008;359:262-73.

Diehl CL, Brost BC, Hogan MC, Elesber AA, Offord KP, Turner ST, et al. Preeclampsia as a risk factor for cardiovascular disease later in life: validation of a preeclampsia questionnaire. Am J Obstet Gynecol 2008;198:e11-3.

Xia Y, Zhou CC, Ramin SM, Kellems RE. Angiotensin receptors, autoimmunity, and preeclampsia. J Immunol 2007;179:3391-5.

Chelbi ST, Vaiman D. Genetic and epigenetic factors contribute to the onset of preeclampsia. Mol Cell Endocrinol 2008;282:120-9.

Ilekis JV, Reddy UM, Roberts JM. Preeclampsia -a pressing problem: an executive summary of a National Institute of Child Health and Human Development workshop. Reprod Sci 2007;14:508-23.

Ananth CV. Epidemiologic approaches for studying recurrent pregnancy outcomes: challenges and implications for research. Semin Perinatol 2007; 31:196-201.

Althabe F, Bergel E, Cafferata ML, Gibbons L, Ciapponi AM, Alemán A, et al. Strategies for improving the quality of health care in maternal and child health in low-and middle-income countries: an overview of systematic reviews. Paediatr Perinat Epidemiol 2008;22:42-60.

Gammill HS, Roberts JM. Emerging concepts in preeclampsia investigation. Front Biosci 2007;12:2403-11.

Cnossen JS, van der Post JAM, Mol BWJ, Khan KS, Meads CA, ter Riet G. Prediction of preeclampsia: a protocol for systematic reviews of test accuracy. BMC Pregnancy Childbirth 2006;6:29.

Sibai B, Dekker G, Kupferminc M. Preeclampsia. Lancet 2005;365:785-89.

República de Colombia. Departamento Administrativo Nacional de Estadísticas. Defunciones 2006. Visitado en 2008 Ago 07. Disponible en: http://www.dane.gov.co/index.php?option=com_content&task=category §ionid=16&id=395&Itemid=891.

Cáceres FM, Díaz LA. Mortalidad materna en el Hospital Universitario Ramón González Valencia, 1994-2004. Rev Colomb Obstet Ginecol 2007;58:99-107.

Boada CL, Cotes M. Plan de choque para la reducción de la mortalidad materna. Visitado en 2008 Ago 07. Disponible en: http://www.profamilia.org.co/003_social/pdf/plan_choque.pdf.

Mulla ZD, González-Sánchez JL, Nuwayhid BS. Descriptive and clinical epidemiology of preeclampsia and eclampsia in Florida. Ethn Dis 2007;17:736-41.

Haelterman E, Qvist R, Barlow P, Alexander S. Social deprivation and poor access to care as risk factors for severe preeclampsia. Eur J Obstet Gynecol Reprod Biol 2003;111:25-32.

Chappell LC, Enye S, Seed P, Briley AL, Poston L, Shennan AH. Adverse perinatal outcomes and risk factors for preeclampsia in women with chronic hypertension: a prospective study. Hypertension 2008;51:1002-9.

Montoro MN, Kjos SL, Chandler M, Peters RK, Xiang AH, Buchanan TA. Insulin resistance and preeclampsia in gestational diabetes mellitus. Diabetes Care 2005;28:1995-2000.

Out HJ, Bruinse HW, Christiaens GC, van Vliet M, de Groot PG, Nieuwenhuis HK, et al. A prospective, controlled multicenter study on the obstetric risks of pregnant women with antiphospholipid antibodies. Am J Obstet Gynecol 1992;167:26-32.

Cnattingius S, Reilly M, Pawitan Y, Lichtenstein P. Maternal and fetal genetic factors account for most of familial aggregation of preeclampsia: a population based Swedish cohort study. Am J Med Genet A 2004;130A:365-71.

Serrano NC, Díaz LA. ¿Qué tanto influyen los factores genéticos y medioambientales en la susceptibilidad para desarrollar preeclampsia? MedUNAB 2005;8:159-64.

Bodnar LM, Catov JM, Klebanoff MA, Ness RB, Roberts JM. Prepregnancy body mass index and the occurrence of severe hypertensive disorders of pregnancy. Epidemiology 2007;18:234-9.

Erez O, Vardi IS, Hallak M, Hershkovitz R, Dukler D, Mazor M. Preeclampsia in twin gestations: association with IVF treatments, parity and maternal age. J Matern Fetal Neonatal Med 2006;19:141-6.

Sibai BM, Gordon T, Thom E, Caritis SN, Klebanoff M, McNellis D, et al. Risk factors for preeclampsia in healthy nulliparous women: a prospective multicenter study. The Nacional Institute of Chile Health and Human Development Network of Maternal-Fetal Medicine Units. Am J Obstet Gynecol 1995;172:642-8.

Dildy GA 3rd, Belfort MA, Smulian JC. Preeclampsia: recurrence and prevention. Semin Perinatol 2007;20:135-41.

England L, Zhang J. Smoking and risk of preeclampsia: a systematic review. Front Biosci 2007;12:2471-83.

Belogolovkin V, Eddleman KA, Malone FD, Sullivan L, Ball RH, Nyberg DA, et al. The effect of low body mass index on the development of gestational hypertension and preeclampsia. J Matern Fetal Neonatal Med 2007;20:509-13.

Mostello D, Kallogjeri D, Tungsiripat R, Leet T. Recurrence of preeclampsia: effects of gestational age at delivery of the first pregnancy, body mass index, paternity, and interval between births. Am J Obstet Gynecol 2008;199:55.e1-7.

Conde-Agudelo A, Rosas-Bermúdez A, Kafury-Goeta AC. Effects of birth spacing on maternal health: a systematic review. Am J Obstet Gynecol 2007;196:297-308.

Elsmén E, Källén K, Maršal K, Hellström-Westas L. Fetal gender and gestational-age-related incidence of preeclampsia. Acta Obstet Gynecol 2006;85:1285-91.

RasmussenS, Irgens LM. Pregnancy-induced hypertension in women who were born small. Hypertension 2007;49:806-12.

Borzychowski AM,Sargent IL, Redman CW. Inflammation and preeclampsia. Semin Fetal Neonatal Med 2006;11:309-16.

Haelterman E, Marcoux S, Croteau A, Dramaix M. Population-based study on occupational risk factors for preeclampsia and gestational hypertension. Scand J Work Environ Health 2007;33:304-17.

Sánchez SE, Qiu C, Perales MT, Lam N, García P, Williams MA. Intimate partner violence (IPV) and preeclampsia among Peruvian women. Eur J Obstet Gynecol Reprod Biol 2008;137:50-5.

Ilekis JV, Reddy UM, Roberts JM. Preeclampsia -a pressing problem: an executive summary of a National Institute of Child Health and Human Development workshop. Reprod Sci 2007;14:508-23.

Dekker G, Robillard PY. Preeclampsia: Is the immune maladaptation hypothesis still standing? An epidemiological update. J Reprod Immunol 2007;76:8-16.

Luo ZC, An N, Xu HR, Larante A, Audibert F, Fraser WD. The effects and mechanisms of primiparity on the risk of preeclampsia: a systematic review. Paediatr Perinat Epidemiol 2007;21:36-45.

Zhang J, Patel G.Partner change and perinatal outcomes: a systematic review. Paediatr Perinat Epidemiol 2007;21:46-57.

Lie RT. Intergenerational exchange and perinatal risks: a note on interpretation of generational recurrence risks. Paediatr Perinat Epidemiol 2007;21:13-8.

Conde-Agudelo A, Belizán JM. Risk factors for preeclampsia in a large cohort of Latin American and Caribbean women. Br J Obstet Gynecol 2000;107:75-83.

Stampfer MJ, Ridker PM, Dzau VJ. Risk factor criteria. Circulation 2004;109:IV3-5.

Silva LM, Coolman M, Steegers EA, Jaddoe VW, Moll HA, Hofman A, et al. Low socioeconomic status is a risk factor for preeclampsia: the Generation R Study. J Hypertens 2008;26:1200-8.

McCaw-Binns AM, Ashley DE, Knight LP, MacGillivray I, Golding J. Strategies to prevent eclampsia in a developing country: I. Reorganization of maternity services. Int J Gynecol Obstet 2004;87:286-94.

Tlebere P, Jackson D, Loveday M, Matizirofa L, Mbombo N, Doherty T, et al. Community-based situation analysis of maternal and neonatal care in South Africa to explore factors that impact utilization of maternal health services J Midwifery Womens Health 2007;52:342-50.

Say L, Raine R. A systematic review of inequalities in the use of maternal health care in developing countries: examining the scale of the problem and the importance of context. Bull WHO 2007;85:812-9.

Askie LM, Duley L, Henderson-Smart DJ, Stewart LA; PARIS Collaborative Group. Antiplatelet agents for prevention of preeclampsia: a meta-analysis of individual patient data. Lancet 2007;369:1791-8.

Hofmeyr GJ, Duley L, Atallah A. Dietary calcium supplementation for prevention of preeclampsia and related problems: a systematic review and commentary. BJOG 2007;114:933-43.

Trumbo PR, Ellwood KC. Supplemental calcium and risk reduction of hypertension, pregnancy-induced hypertension, and preeclampsia: an evidence-based review by the US Food and Drug Administration. Nutr Rev 2007;65:78-87.

Horvath A, Koletzko B, Szajewska H.Effect of supplementation of women in high-risk pregnancies with long-chain polyunsaturated fatty acids on pregnancy outcomes and growth measures at birth: a meta-analysis of randomized controlled trials. Br J Nutr 2007;98:253-9.

Makrides M, Duley L, Olsen SF.Marine oil, and other prostaglandin precursor, supplementation for pregnancy uncomplicated by pre-eclampsia or intrauterine growth restriction. Cochrane Database Syst Rev 2006;3:CD003402.

Polyzos NP, Mauri D, Tsappi M, Tzioras S, Kamposioras K, Cortinovis I, et al. Combined vitamin C and E supplementation during pregnancy for preeclampsia prevention: a systematic review. Obstet Gynecol Surv 2007;62:202-6.

Duley L, Henderson-Smart DJ, Meher S, King JF. Antiplatelet agents for preventing preeclampsia and its complications. Cochrane Database Syst Rev 2007;2: CD004659.

Meher S, Duley L. Rest during pregnancy for preventing preeclampsia and its complications in women with normal blood pressure. Cochrane Database Syst Rev 2006;2:CD005939.

Hegaard HK, Pedersen BK, Nielsen BB, Damm P. Leisure time physical activity during pregnancy and impact on gestational diabetes mellitus, preeclampsia, preterm delivery and birthweight: a review. Acta Obstet Gynecol Scand 2007;86:1290-6.

Duley L, Henderson-Smart D, Meher S. Altered dietary salt for preventing preeclampsia, and its complications. Cochrane Database Syst Rev 2005;4: CD005548.

Meher S, Duley L.Nitric oxide for preventing preeclampsia and its complications. Cochrane Database Syst Rev 2007;2:CD006490.

NeugebauerJ, Zanré Y, Wacker J. Riboflavin supplementation and preeclampsia. Int J Gynaecol Obstet 2006;93:136-7.

Thaver D, Saeed MA, Bhutta ZA. Pyridoxine (vitamin B6) supplementation in pregnancy. Cochrane Database Syst Rev 2006;2:CD000179.

Wen SW, Chen XK, Rodger M, White RR, Yang Q, Smith GN, et al. Folic acid supplementation in early second trimester and the risk of preeclampsia. Am J Obstet Gynecol 2008;198:45.e1-7.

Bodnar LM, Tang G, Ness RB, Harger G, Roberts JM. Periconceptional multivitamin use reduces the risk of preeclampsia. Am J Epidemiol 2006;164:470-7.

Hyppönen E. Vitamin D for the prevention of preeclampsia? A hypothesis. Nutr Rev 2005;63:225-32.

Todros T, Verdiglione P, Oggè G, Paladini D, Vergani P, Cardaropoli S. Low incidence of hypertensive disorders of pregnancy in women treated with spiramycin for toxoplasma infection. Br J Clin Pharmacol 2006;61:336-40.

Kazy Z, Puhó EH, Czeizel AE. The possible preterm birth preventive effect of ampicillin during pregnancy. Arch Gynecol Obstet 2006;274:215-21.

Churchill D, Beevers GD, Meher S, Rhodes C. Diuretics for preventing preeclampsia. Cochrane Database Syst Rev 2007;1:CD004451.

Meher S, Duley L. Progesterone for preventing preeclampsia and its complications. Cochrane Database Syst Rev 2006;4:CD006175.

Chang EY, Barbosa E, Paintlia MK, Singh A, Singh I. The use of N-acetylcysteine for the prevention of hypertension in the reduced uterine perfusion pressure model for preeclampsia in Sprague-Dawley rats. Am J Obstet Gynecol 2005;193:952-6.

Takei H, Nakai Y, Hattori N, Yamamoto M, Takeda S, Yamamoto M, et al. The herbal medicines Saireito and Boiogito improve the hypertension of preeclamptic rats induced by Nomega-Nitro-L-arginine methyl ester. Phytomedicine 2007;14:591-600.

de Moura RS, Resende AC, Moura AS, Maradei MF. Protective action of a hydroalcoholic extract of a vinifera grape skin on experimental preeclampsia in rats. Hypertens Pregnancy 2007;26:89-100.

Meher S, Duley L. Garlic for preventing preeclampsia and its complications. Cochrane Database Syst Rev 2006;3:CD006065.

Caughey AB, Lee KA. CPAP for the prevention of preeclampsia: is this a clinically promising intervention? Sleep Med 2007;9:1-2.

Leduc L, Dubois E, Takser L, Rey E, David M. Dalteparin and low-dose aspirin in the prevention of adverse obstetric outcomes in women with inherited thrombophilia. J Obstet Gynaecol Can 2007;29:787-93.

Easterling TR, Brateng D, Schmucker B, Brown Z, Millard SP. Prevention of preeclampsia: a randomized trial of atenolol in hyperdynamic patients before onset of hypertension. Obstet Gynecol 1999;93:725-33.

Lees C, Valensise H, Black R, Harrington K, Bviers S, Romanini C, et al. The efficacy and fetal-maternal cardiovascular effects of transdermal glyceryl trinitrate in the prophylaxis of preeclampsia and its complications: a randomized double-blind placebo-controlled trial. Ultrasound Obstet Gynecol 1998;12:334-8.

D'Angelo D, Williams L, Morrow B, Cox S, Harris N, Harrison L, et al. Preconception and interconception health status of women whore cently gave birthto alive born infant-Pregnancy Risk Assessment Monitoring System (PRAMS), United States, 26 reporting areas, 2004. MMWR Surveill Summ 2007;56:1-35.

Geib LT, Vargas Filho EF, Geib D, Mesquita DI, Nunes ML. Prevalência e determinantes maternos do consumo de medicamentos na gestação por classe de risco em mães de nascidos vivos. Cad Saúde Pública 2007;23:2351-62.

Guimarães GP, Monticelli M. Falta de motivación de las madres púerperas para la práctica del método de Mamá Canguro. Rev Gaucha Enferm 2007;28:11-20.

Zasloff E, Schytt E, Waldenström U.First time mothers' pregnancy and birth experiences varying by age. Acta Obstet Gynecol Scand 2007;86:1328-36.

Kerber KJ, de Graft-Johnson JE, Bhutta ZA, Okong P, Starrs A, Lawn JE. Continuum of care for maternal, newborn, and child health: from slogan to service delivery. Lancet 2007;370:1358-69.

Vecino-Ortiz AI. Determinants of demand for antenatal care in Colombia. Health Policy 2008;86:363-72.

Mendoza-Sassi RA, Cesar JA, Ulmi EF, Mano PS, Dall'Agnol MM, Neumann NA. Avaliando o conhecimento sobre pré-natal e situações de risco à gravidez entre gestantes residentes na periferia da cidade de Rio Grande, Rio Grande do Sul, Brasil. Cad Saúde Pública 2007;23:2157-66.

Lima de Souza N, Fernandes Araújo AC, Dantas de Azevedo G, Bezerra Jerônimo SM, Barbosa Lde M, Lima de Sousa NM. [Maternal perception of premature birth and experience of preeclampsia pregnancy]. Rev Saúde Pública 2007;41:704-10.

Soya K, Kumari VP, Mumthas K. Self-care activities of pregnancy induced hypertension and maternal outcome. Nurs J India 2003;94:58-60.

Repke JT, Power ML, Holzman GB, Schulkin J. Hypertension in pregnancy and preeclampsia. Knowledge and clinical practice among obstetrician-gynecologists. J Reprod Med 2002;47:472-6.

Leeners B, Rath W, Kuse S, Neises M, Neumaier-Wagner P. Satisfaction with medical information in women with hypertensive disorders in pregnancy. J Psychosom Res 2006;60:39-44.

Xiong X, Mayes D, Demianczuk N, Olson D, Davidge S, Newburn-Cook C, Saunders L. Impact of pregnancy-induced hypertension on fetal growth. Am J Obstet Gynecol 1999;180:207-13.

Flóres-Nava G, Lino-Araújo M, López-Padilla M. Morbilidad y mortalidad en neonatos de madres con preeclampsia severa. Rev Méx Pediatr 2002;69:14-8.

Redman CW, Sacks GP, Sargent IL. Preeclampsia: an excessive maternal inflammatory response to pregnancy. Am J Obstet Gynecol 1999;180:499-506.

Xiong X, Fraser WD. Impact of pregnancy-induced hypertension on birthweight by gestational age. Paediatr Perinat Epidemiol 2004;18:186-91.

Habli M, Levine RJ, Qian C, Sibai B. Neonatal outcomes in pregnancies with preeclampsia or gestational hypertension and in normotensive pregnancies that delivered at 35, 36, or 37 weeks of gestation. Am J Obstet Gynecol 2007;197:406.e1-7.

Harskamp RE, Zeeman GG. Preeclampsia: at risk for remote cardiovascular disease. Am J Med Sci 2007;334:291-5.

Brown DW, Dueker N, Jamieson DJ, Cole JW, Wozniak MA, Stern BJ, Giles WH, Kittner SJ. Preeclampsia and the risk of Ischemic stroke among young women: results from the Stroke Prevention in Young Women Study. Stroke 2006;37:1055-9.

Libby G, Murphy DJ, McEwan NF, Greene SA, Forsyth JS, Chien PW, et al. Preeclampsia and the later development of type 2 diabetes in mothers and their children: an intergenerational study from the Walker Cohort. Diabetologia 2007;50:523-30.

AndersonCM. Preeclampsia: exposing future cardiovascular risk in mothers and their children. J Obstet Gynecol Neonatal Nurs 2007;36:3-8.

Wolfberg AJ, Lee-Parritz A, Peller AJ, Lieberman ES. Association of rheumatologic disease with preeclampsia. Obstet Gynecol 2004;103:1190-3.

Vatten LJ, Skjaerven R. Is preeclampsia more than one disease? Br J Obstet Gynecol 2004;111:298-302.

Rigó J, Boze T, Derzsy Z, Derzbach L, Treszl A, Lázár L, et al. Family history of early-onset cardiovascular disorders is associated with a higher risk of severe preeclampsia. Eur J Obstet Gynecol Reprod Biol 2006;128:148-51.

Holtzman NA. What role for public health in genetics and vice versa? Comm Genet 2006;8:20.

Cómo citar

1.
Díaz-Martínez LA, Serrano-Díaz NC. Oportunidades de investigación en preeclampsia, desde la perspectiva de prevención primaria. Un artículo de reflexión. Rev. Colomb. Obstet. Ginecol. [Internet]. 30 de septiembre de 2008 [citado 6 de octubre de 2022];59(3):206-15. Disponible en: https://revista.fecolsog.org/index.php/rcog/article/view/405

Descargas

Los datos de descargas todavía no están disponibles.

Descargas

Publicado

2008-09-30

Número

Sección

Artículo de Reflexión